✦ LIBER ✦

An open-label, switchover trial to assess the safety and efficacy of agalsidase beta in patients with Fabry disease treated with agalsidase alfa enzyme replacement therapy

✍ Scribed by Richards, Sarah; Laney, Dawn; Pervaiz, Muhammad A.; Shankar, Suma

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy of Enzyme Replacemen

✍ J. Edmond Wraith; Anna Tylki-Szymanska; Nathalie Guffon; Y. Howard Lien; Michel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 198 KB

An open-label, switchover trial to asses

✍ Richards, Sarah; Laney, Dawn; Pervaiz, M. Ali; Shankar, Suma 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Clinical observations on enzyme replacem

✍ Lin, Hsiang-Yu; Huang, Yu-Hsiu; Liao, Hsuan-Chieh; Liu, Hao-Chuan; Hsu, Ting-Ron 📂 Article 📅 2014 🏛 Elsevier Science 🌐 Chinese ⚖ 414 KB

Enzyme replacement therapy in a patient

✍ Tanaka, Akemi; Takeda, Taisuke; Hoshina, Takao; Fukai, Kazuyoshi; Yamano, Tsunek 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 281 KB

Effects of enzyme replacement therapy wi

✍ F Dehout; A Schwarting; M Beck; A Mehta; R Ricci; U Widmer; on behalf of the FOS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

A 4-year study of the efficacy and toler

✍ Whybra, Catharina; Miebach, Elke; Mengel, Eugen; Gal, Andreas; Baron, Karin; Bec 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 883 KB